BNTX vs VALN
BioNTech SE and Valneva SE, side by side — 7 fiscal years reported in EUR, drawn from SEC filings.
Most recent reported year
| Metric | BNTX | VALN |
|---|---|---|
| Revenue | €2.9B | €174.7M |
| Net income | €-1.1B | €-115.2M |
| Gross margin | 77.6% | 38.7% |
| Net margin | −39.6% | −66.0% |
| Return on equity | −5.9% | · |
| Diluted EPS | −€4.70 | −€0.68 |
| Dividend / share | · | · |
| Payout ratio | · | · |
| Free cash flow | €280.9M | €-57.3M |
| Equity | · | · |
| Net debt / equity | · | 0.65× |
| Current ratio | 7.54× | 2.38× |
| Revenue CAGR 5y | 42.9% | 9.6% |
| Profit CAGR 5y | · | · |
BNTX bills 16.4× the revenue of VALN, and both closed the last reported year at a loss.
The stronger figure of the pair is set in bold. That is arithmetic, not a recommendation — this page does not pick a winner. "·" marks a figure not available in our data.
7 years side by side
| Fiscal year | BNTX | VALN |
|---|---|---|
| FY2025 | €2.9B | €174.7M |
| FY2024 | €2.8B | €169.6M |
| FY2023 | €3.8B | €153.7M |
| FY2022 | €17.3B | €361.3M |
| FY2021 | €19.0B | €348.1M |
| FY2020 | €482.3M | €110.3M |
| FY2019 | €108.6M | €126.2M |
Bottom line
| Fiscal year | BNTX | VALN |
|---|---|---|
| FY2025 | €-1.1B | €-115.2M |
| FY2024 | €-665.3M | €-12.2M |
| FY2023 | €930.3M | €-101.4M |
| FY2022 | €9.4B | €-143.3M |
| FY2021 | €10.3B | €-73.4M |
| FY2020 | €15.2M | €-64.4M |
| FY2019 | €-179.1M | €-811,000 |
7 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +€2,695,241,000 | BNTX |
| FY2024 | +€2,581,521,000 | BNTX |
| FY2023 | +€3,665,287,000 | BNTX |
| FY2022 | +€16,949,297,000 | BNTX |
| FY2021 | +€18,628,614,000 | BNTX |
| FY2020 | +€371,979,000 | BNTX |
| FY2019 | −€17,596,000 | VALN |
The higher-revenue side has changed between BNTX and VALN over this period. The gap has widened since the earliest year compared.
7 of 9 comparable fiscal years — a year missing data on either side is not counted.
6 fiscal years
| Fiscal year | Difference | Ahead |
|---|---|---|
| FY2025 | +26.4 pp | BNTX |
| FY2024 | −17.0 pp | VALN |
| FY2023 | +90.3 pp | BNTX |
| FY2022 | +94.2 pp | BNTX |
| FY2020 | +61.5 pp | BNTX |
| FY2019 | −163.6 pp | VALN |
The higher net margin has changed hands between BNTX and VALN over this period.
6 of 9 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
BNTX's net margin has been more volatile than VALN's over the 6 comparable fiscal years — 70.0 percentage points of standard deviation against 26.6.
6 of 9 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in net margin changed hands between BNTX and VALN over these 6 fiscal years — BNTX led in 4 and VALN in 2.
6 of 9 comparable fiscal years — a year missing data on either side is not counted.
Standard deviation, each side
BNTX's return on equity has been more volatile than VALN's over the 3 comparable fiscal years — 86.2 percentage points of standard deviation against 23.6.
3 of 7 comparable fiscal years — a year missing data on either side is not counted.
Year by year
The lead in return on equity changed hands between BNTX and VALN over these 3 fiscal years — BNTX led in 2 and VALN in 1.
3 of 7 comparable fiscal years — a year missing data on either side is not counted.